Clinicopathologic analysis of bcl-2 immunostaining in breast carcinoma.

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

Clinicopathologic analysis of bcl-2 immunostaining in breast carcinoma.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc - 1 Jun 1996

Visscher D W, Sarkar F, Tabaczka P, Crissman J

Abstract excerpt

Tissue sections of 81 breast carcinomas and 19 benign breast tissues were immunostained with a monoclonal antibody to the bcl-2 gene product, a cytoplasmic protein that regulates apoptosis. The degree of immunoreactivity was then compared with clinicopathologic parameters and to immunostaining fo...

Topics

Breast Diseases
Breast Neoplasms
Cell Nucleus
Female
Humans
Immunohistochemistry
Mutation
Neoplasm Recurrence, Local
Proto-Oncogene Proteins c-bcl-2
Tumor Suppressor Protein p53

Source

Open in PubMed

Identifiers

PMID: 8782201

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 30 Aug 2026. Prepared record publication-8782201-2026-08-30.1. Manifest publication-graph-cohort-2026-08-30.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 30 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics